Obstetricia y Ginecología, Pediatría, Medicina Preventiva y Salud Pública, Toxicología, Medicina Legal y Forense y Parasitología
Departamento
Universidad del País Vasco/Euskal Herriko Unibertsitatea
Lejona, EspañaUniversidad del País Vasco/Euskal Herriko Unibertsitatea-ko ikertzaileekin lankidetzan egindako argitalpenak (16)
2024
-
Evaluation of Genetic Variants Associated with the Risk of Thiopurine-Related Pancreatitis: A Case Control Study from ENEIDA Registry
Digestive Diseases, Vol. 42, Núm. 3, pp. 257-264
2022
-
Caffeine, D-glucuronolactone and Taurine Content in Energy Drinks: Exposure and Risk Assessment
Nutrients, Vol. 14, Núm. 23
-
Immigrant IBD Patients in Spain Are Younger, Have More Extraintestinal Manifestations and Use More Biologics Than Native Patients
Frontiers in Medicine, Vol. 9
-
Nationwide COVID-19-EII Study: Incidence, Environmental Risk Factors and Long-Term Follow-Up of Patients with Inflammatory Bowel Disease and COVID-19 of the ENEIDA Registry
Journal of Clinical Medicine, Vol. 11, Núm. 2
2021
-
Naphthyridine derivatives induce programmed cell death in naegleria fowleri
Pharmaceuticals, Vol. 14, Núm. 10
2020
-
Informe del Comité Científico de la Agencia Española de Seguridad Alimentaria y Nutrición (AESAN) sobre el riesgo asociado al consumo de complementos alimenticios que contienen curcumina como ingrediente
Revista del Comité Científico de la AESAN, Núm. 32, pp. 85-112
2018
-
Genomic analyses of human European diversity at the southwestern edge: Isolation, African influence and disease associations in the Canary Islands
Molecular Biology and Evolution, Vol. 35, Núm. 12, pp. 3010-3026
2008
-
Galectin and aldolase-like molecules are responsible for the specific IgE response in humans exposed to Dirofilaria immitis
Parasite Immunology, Vol. 30, Núm. 11-12, pp. 596-602
2006
-
In vitro activities of voriconazole and five licensed antifungal agents against Candida dubliniensis: Comparison of CLSI M27-A2, Sensitive YeastOne, disk diffusion, and Etest methods
Microbial Drug Resistance, Vol. 12, Núm. 4, pp. 246-251
2004
-
Evaluation of API ID 32C® and VITEK-2® to identify Candida dubliniensis
Diagnostic Microbiology and Infectious Disease, Vol. 50, Núm. 3, pp. 219-221
2003
-
Antifungal activity of the echinocandin anidulafungin (VER002, LY-303366) against yeast pathogens: A comparative study with M27-A microdilution method
Journal of Antimicrobial Chemotherapy, Vol. 51, Núm. 1, pp. 163-166
-
Performance of Bacticard™ Candida compared with the germ tube test for the presumptive identification of Candida albicans
Mycoses, Vol. 46, Núm. 11-12, pp. 467-470
2000
-
Comparative in vitro antifungal activity of amphotericin B lipid complex, amphotericin B and fluconazole
Chemotherapy, Vol. 46, Núm. 4, pp. 235-244
-
In vitro susceptibility of Candida dubliniensis to current and new antifungal agents
Chemotherapy, Vol. 46, Núm. 6, pp. 395-401
1999
-
Multicenter evaluation of Neo-Sensitabs, a standardized diffusion method for yeast susceptibility testing
Revista Iberoamericana de Micologia, Vol. 16, Núm. 2, pp. 92-96
1996
-
Aportaciones del comité de la AEM para la estandarización de pruebas de estudio de la sensibilidad in vitro a los antifúngicos: Método de difusión en disco
Revista Iberoamericana de Micologia, Vol. 13, Núm. SUPPL. 2